MedPath

通化中辰药业有限责任公司

Ownership
-
Established
2000-11-03
Employees
-
Market Cap
-
Website
www.thzcyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

人参天麻药酒

Approval Number
国药准字Z22021697
Approval Date
Apr 10, 2025
NMPA

三肾丸

Approval Number
国药准字Z22021699
Approval Date
Apr 10, 2025
NMPA

Compound Vitamin U Capsules

Product Name
复方维生素U胶囊
Approval Number
国药准字H22021313
Approval Date
May 27, 2020
NMPA

Methionine and cholinie Bitartrate Table

Product Name
蛋氨酸重酒石酸胆碱片
Approval Number
国药准字H22025331
Approval Date
May 25, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H22023740
Approval Date
May 25, 2020
NMPA

Furazolidon Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H22021031
Approval Date
May 25, 2020
NMPA

Vitamin U,Belladonne and Aluminium Capsu

Product Name
维U颠茄铝胶囊
Approval Number
国药准字H22025364
Approval Date
May 25, 2020
NMPA

Metronidazole Capsules

Product Name
甲硝唑胶囊
Approval Number
国药准字H22021046
Approval Date
May 25, 2020
NMPA

Choramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H22021091
Approval Date
May 25, 2020
NMPA

Lappaconite Hydrobromide Tablets

Product Name
氢溴酸高乌甲素片
Approval Number
国药准字H22021048
Approval Date
May 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.